GMR’s IPO Is Really a Debt-and-Control Story

LEWISVILLE, Texas, May 4, 2026 — GMR Solutions is not bringing a plain-vanilla healthcare services IPO to market. The KKR-backed emergency medical services platform launched its NYSE deal on Monday at $22 to $25 a share for 31.9 million Class A shares, a structure that could raise roughly $798 million before any greenshoe. What makes the book worth watching is the shape around it: funds affiliated with KKR, Ares and HPS are expected to buy $350 million of private-placement warrants alongside the float, giving the deal more visible sponsorship than most sponsor exits now in market.

That support matters because the story public investors are being asked to underwrite is as much balance-sheet repair as operating scale. GMR said IPO proceeds will first redeem certain outstanding Series B preferred stock, with remaining proceeds, together with the warrant placement and cash on hand, earmarked to repay part of Global Medical Response’s first-lien term loan due 2032. The company has size, national reach and real operating heft, but it is still carrying a leveraged capital structure: 2025 interest expense ran to $422.7 million, against $206.2 million of net income and $5.74 billion of revenue.

The operating picture is sturdy, but not clean. Revenue slipped from $5.98 billion in 2024 to $5.74 billion in 2025, even as net income improved sharply and adjusted EBITDA reached about $1.19 billion. GMR pitches itself as the only national fully integrated air-and-ground EMS provider, operating in roughly 1,400 counties and touching more than 60% of the U.S. population through brands including American Medical Response, Air Evac Lifeteam, REACH, Guardian Flight and Med-Trans. That scale is a real differentiator, especially in a market where rural access and alternate-site care keep getting more attention. It also means investors will need to separate durable emergency-response demand from the slower, more financial work of deleveraging a private-equity-built platform.

The syndicate is another signal. J.P. Morgan is leading a book that also includes KKR Capital Markets, BofA, Barclays, Goldman, Citi, Evercore, Morgan Stanley and UBS, with four co-managers added in the latest launch. Even so, this is still a controlled-company IPO: the prospectus says KKR will hold about 75.5% of voting power after the offering and private placement, assuming full exercise of outstanding company warrants. That leaves GMR as a useful read on current IPO demand: a scaled issuer with recognizable assets, named support and a real refinancing plan, but one still asking public buyers to fund a cleaner capital structure before they can own a simpler equity story.